Short-term safety profile of Sars-Cov2 vaccination on glucose control: Continuous glucose monitoring data in people with autoimmune diabetes.
CGM
Diabetes
Glucose control
Sars-Cov-2
Vaccination
Journal
Diabetes research and clinical practice
ISSN: 1872-8227
Titre abrégé: Diabetes Res Clin Pract
Pays: Ireland
ID NLM: 8508335
Informations de publication
Date de publication:
Sep 2021
Sep 2021
Historique:
received:
13
07
2021
revised:
16
08
2021
accepted:
19
08
2021
pubmed:
28
8
2021
medline:
25
11
2021
entrez:
27
8
2021
Statut:
ppublish
Résumé
In patients with autoimmune diabetes no significant differences were observed in glucose control, expressed as time in range evaluated by continuous glucose monitoring comparing the 3 days after Sars-Cov2 vaccine with the 14 days preceding the vaccine.
Identifiants
pubmed: 34450248
pii: S0168-8227(21)00381-8
doi: 10.1016/j.diabres.2021.109022
pmc: PMC8383474
pii:
doi:
Substances chimiques
Blood Glucose
0
RNA, Viral
0
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
109022Informations de copyright
Copyright © 2021 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Diabetes Obes Metab. 2021 Jun;23(6):1397-1401
pubmed: 33502076
Lancet Diabetes Endocrinol. 2020 Sep;8(9):782-792
pubmed: 32687793
Diabetes Obes Metab. 2021 Jul;23(7):1624-1630
pubmed: 33764666
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Diabetes Res Clin Pract. 2020 Nov;169:108454
pubmed: 32971157
Cardiovasc Diabetol. 2020 Oct 1;19(1):164
pubmed: 33004045
Diabetes Care. 2020 Aug;43(8):e86-e87
pubmed: 32503838
Diabetes Care. 2019 Jun;42(6):1147-1154
pubmed: 30728224